Skip to main content

LSPediA Selected by Kowa Pharmaceuticals to Provide Verification Router Service

Farmington Hills, MI – December 19, 2018 – LSPediA LLC, a leading software and service provider for the pharmaceutical industry, today announced an expansion of their existing business relationship with Kowa Pharmaceuticals.

Kowa Pharmaceuticals

Kowa Pharmaceuticals America, Inc. specializes in acquiring, developing, licensing, and marketing pharmaceutical products for cardiovascular conditions. Kowa began partnering with LSPediA in 2015 for DSCSA—a partnership that quickly grew to include adoption of EPCIS system, WarehouseEdge, and CMO management consulting.

LSPediA now provides Verification Router Services (VRS) to Kowa including Saleable Returns Verification, Non-saleable Returns Decommission, Lookup Directory Synchronization,and VRS Dashboard. Through its partnership with LSPediA, Kowa has responded to thousands of VRS requests from the leading wholesalers in the US. LSPediA’s VRS allows companies to verify serialized Rx products for authenticity, decommission unsaleable returns, and initiate notification for recalls or counterfeit.

“This puts in place a vital piece ofour DSCSA compliance,” said Joseph Barna, Chief Financial Officer. “As a branded drug manufacturer who cares deeply about our patients’ health and safety, we are aligned with LSPediA to lead the pharmaceutical industry inserialization and verification.”

“LSPediA was the obvious choice for VRS,” stated Ken Riester, Vice President Trade and SupplyChain. “LSPediA’s top-of-line technology provides turnkey compliance, strategic insight, and—most importantly—interoperability with our wholesale customers and retail customers. Partnering with LSPediA made our entire organization feel confident in the outcomes, and our customers feel supported in their DSCSA efforts.”  

VRS fulfills an important DSCSA requirement by enabling pharmaceutical wholesalers and dispensers to validate serialized products so they can be put back into commercial distribution. Kowa is one of 11 manufacturers participating in the HDA’s VRS pilot program, which also includes five wholesalers, and nine solution providers.

About Kowa Pharmaceuticals

KowaPharmaceuticals America, Inc., headquartered in Montgomery, Alabama, is currentlyfocused primarily in cardiometabolic diseases. Learn more at

About LSPediA – Life Sciences Solutions

LSPediA leads the pharmaceutical serialization technology with integrated solutionsincluding RxChain® EPCIS, RxChain™ Edge, and IoT VRS.  Pharmaceuticalmanufacturers, wholesale distributors, retail pharmacies implement LSPediAsolutions for turnkey DSCSA compliance, counterfeit protection, supply chainefficiency.  Contact us at (248) 973-2008 or [email protected],or visit tolearn more.